Welcome to our dedicated page for CTS SEC filings (Ticker: CTS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CTS Corporation (NYSE: CTS) SEC filings page aggregates the company’s regulatory disclosures, including the Form 8-K current reports cited in its public communications. These filings provide structured information on topics such as quarterly financial results, material definitive agreements, leadership changes, and board composition, giving investors a detailed view of how CTS reports key events and obligations.
CTS uses Form 8-K to furnish earnings press releases that summarize net sales, net earnings, margins, cash flow, and guidance ranges for annual sales and adjusted diluted earnings per share. These filings often include or reference investor presentations used in meetings with investors and analysts. The company also explains its use of non-GAAP financial measures alongside U.S. GAAP metrics and describes the categories of adjustments it applies, such as restructuring charges, environmental charges, acquisition-related adjustments, foreign exchange items, non-cash pension items, and certain discrete tax items.
Other CTS filings document material definitive agreements, such as the five-year unsecured revolving credit facility described in a Form 8-K. That filing outlines the size of the revolving credit facility, swing line and letter of credit sublimits, alternative currency sublimit, leverage and interest coverage covenants, and the replacement of a prior unsecured credit facility. Additional 8-K reports cover the appointment or resignation of senior officers, the election of new directors, committee assignments, and related compensation or indemnification arrangements.
On Stock Titan, CTS filings are updated as they become available from EDGAR, and AI-powered summaries can help explain the key points of lengthy documents. Investors can use this page to review CTS’s current reports on operations and financial condition, governance changes, and financing arrangements, as well as to understand how the company frames forward-looking statements and risk factors by referencing its Annual Report on Form 10-K and other filings.
Wasatch Advisors filed an amended Schedule 13G reporting its beneficial ownership in CTS Corp. It reports holding 2,262,448 shares, representing 7.8% of the company’s common stock. Wasatch has sole voting power over 1,538,275 shares and sole dispositive power over all 2,262,448 shares.
The firm states the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of CTS Corp.
CTS Corp officer Pratik Trivedi filed an amended insider trading report to correct a prior tax-withholding entry tied to vesting of restricted stock. On February 5, 2026, 125 shares of common stock were disposed of at $54.19 per share to cover tax obligations.
After this correction, Trivedi directly beneficially owns 7,938 shares of CTS common stock. The amendment states that no other changes were made beyond updating the number of shares withheld for taxes.
CTS Corp President & CEO and director Kieran M. O'Sullivan reported two insider transactions on common stock dated February 9, 2026. He disposed of a total of 6,980 shares through tax-withholding dispositions tied to restricted stock vesting, valued at $55.58 per share. According to the filing, the shares were surrendered to satisfy tax withholding obligations when restricted stock awards vested. After these transactions, he directly owned 403,750 shares of CTS common stock.
Agrawal Ashish reported disposition transactions in a Form 4 filing for CTS. The filing lists transactions totaling 4,314 shares at a weighted average price of $55.58 per share. Following the reported transactions, holdings were 104,229 shares.
CTS Corporation furnished an investor presentation outlining recent performance, strategy, and 2026 guidance. For the twelve months ended December 2025, revenue was $541.3 million with adjusted EBITDA margin of 22.8% and adjusted diluted EPS of $2.23.
The business is increasingly diversified: industrial revenue was $140 million (up 12% year over year), medical revenue $85 million (up 21%), and aerospace & defense revenue $83 million (up 20%), while transportation revenue was $234 million (down 7%). Diversified end markets now represent 57% of revenue.
CTS reported free cash flow of $86.4 million in 2025 and has returned about $300 million to shareholders since 2013 through dividends and repurchases. For 2026, the company targets revenue of $550–$580 million and adjusted diluted EPS of $2.30–$2.45, supported by secular trends in automation, healthcare innovation, and electrification.
CTS Corporation reported stronger results for the fourth quarter and full year 2025, driven by growth in diversified industrial, medical, and aerospace & defense markets and better profitability. Fourth-quarter sales were $137.3 million, up 9% year over year, with diversified end markets up 16% and transportation down 1%. Net earnings rose to $19.7 million, and diluted EPS increased to $0.67 from $0.38, helped by higher gross and EBITDA margins.
For full-year 2025, sales reached $541.3 million, up 5%, while net earnings grew to $65.3 million and diluted EPS to $2.19 from $1.80. Diversified end markets grew 16% and represented 57% of revenue, partially offsetting a 7% decline in transportation revenue. Adjusted gross margin improved to 38.5% and adjusted EBITDA margin to 22.8%. Operating cash flow was $102.1 million and free cash flow $86.4 million, supporting $62 million returned to shareholders in 2025.
For 2026, CTS guides revenue of $550–$580 million and adjusted diluted EPS of $2.30–$2.45, assuming continued growth in diversified markets and softness in commercial-vehicle-related sales, with an expected tax rate of 21–23% excluding discrete items.
CTS Corporation President & CEO Kieran M. O'Sullivan reported a routine tax-related share withholding. On February 6, 2026, he surrendered 3,680 shares of common stock at $55.78 per share to cover tax obligations tied to vesting restricted stock.
After this transaction, O'Sullivan directly beneficially owned 410,730 shares of CTS common stock. The filing describes a non-open-market transaction classified as code F, which typically reflects shares withheld by the company rather than discretionary selling in the market.
CTS Corp's CFO Ashish Agrawal reported an automatic tax-withholding share surrender. On February 5, 2026, he surrendered 931 shares of CTS common stock at $54.19 per share to cover tax withholding upon vesting of restricted stock. Following this transaction, he directly beneficially owned 105,056 CTS shares.
CTS Corp Senior Vice President Pratik Trivedi reported an automatic share surrender to cover taxes. On February 5, 2026, Trivedi surrendered 289 shares of CTS common stock at $54.19 per share to satisfy tax withholding due on vesting of restricted stock. After this withholding transaction, Trivedi directly beneficially owned 8,063 CTS common shares.
CTS Corp chief financial officer Ashish Agrawal reported selling 25,000 shares of CTS common stock on 02/02/2026 at $53 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan entered into on February 27, 2025. Following this sale, Agrawal beneficially owns 105,987 CTS common shares directly.